Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 4
1998 12
1999 3
2000 6
2001 5
2002 1
2003 2
2005 4
2006 8
2007 7
2008 4
2009 8
2010 7
2011 8
2012 8
2013 11
2014 21
2015 19
2016 16
2017 21
2018 29
2019 17
2020 21
2021 19
2022 9
Text availability
Article attribute
Article type
Publication date

Search Results

236 results
Results by year
Filters applied: . Clear all
Page 1
Global brain inflammation in stroke.
Shi K, Tian DC, Li ZG, Ducruet AF, Lawton MT, Shi FD. Shi K, et al. Among authors: shi fd. Lancet Neurol. 2019 Nov;18(11):1058-1066. doi: 10.1016/S1474-4422(19)30078-X. Epub 2019 Jul 8. Lancet Neurol. 2019. PMID: 31296369 Review.
Bone marrow hematopoiesis drives multiple sclerosis progression.
Shi K, Li H, Chang T, He W, Kong Y, Qi C, Li R, Huang H, Zhu Z, Zheng P, Ruan Z, Zhou J, Shi FD, Liu Q. Shi K, et al. Among authors: shi fd. Cell. 2022 Jun 23;185(13):2234-2247.e17. doi: 10.1016/j.cell.2022.05.020. Epub 2022 Jun 15. Cell. 2022. PMID: 35709748 Free article.
Immune interventions in stroke.
Fu Y, Liu Q, Anrather J, Shi FD. Fu Y, et al. Among authors: shi fd. Nat Rev Neurol. 2015 Sep;11(9):524-35. doi: 10.1038/nrneurol.2015.144. Epub 2015 Aug 25. Nat Rev Neurol. 2015. PMID: 26303850 Free PMC article. Review.
TLR-stimulated IRAKM activates caspase-8 inflammasome in microglia and promotes neuroinflammation.
Zhang CJ, Jiang M, Zhou H, Liu W, Wang C, Kang Z, Han B, Zhang Q, Chen X, Xiao J, Fisher A, Kaiser WJ, Murayama MA, Iwakura Y, Gao J, Carman J, Dongre A, Dubyak G, Abbott DW, Shi FD, Ransohoff RM, Li X. Zhang CJ, et al. Among authors: shi fd. J Clin Invest. 2018 Dec 3;128(12):5399-5412. doi: 10.1172/JCI121901. Epub 2018 Oct 29. J Clin Invest. 2018. PMID: 30372424 Free PMC article.
Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial.
Zhang C, Zhang M, Qiu W, Ma H, Zhang X, Zhu Z, Yang CS, Jia D, Zhang TX, Yuan M, Feng Y, Yang L, Lu W, Yu C, Bennett JL, Shi FD; TANGO Study Investigators. Zhang C, et al. Among authors: shi fd. Lancet Neurol. 2020 May;19(5):391-401. doi: 10.1016/S1474-4422(20)30070-3. Lancet Neurol. 2020. PMID: 32333897 Free PMC article. Clinical Trial.
236 results